Annemarie Moseley, COO/EVP Clinical Development at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 37,300 shares at $19.01 ($713K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Open-market sale of $713k BLCM by COO/EVP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.01 | 32,700 | $622K | 87.1% |
| 2 | $19.96 | 2,300 | $46K | 6.4% |
| 3 | $19.96 | 2,300 | $46K | 6.4% |
| Total | $19.13 avg | 37,300 | $713K | 100% |
| Filing → |
| BLCM | SELL | 2015-07-06 | $722K | — | Filing → |